Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

A high-density association screen of 155 ion transport genes for involvement with common migraine.

Nyholt DR, LaForge KS, Kallela M, Alakurtti K, Anttila V, Färkkilä M, Hämaläinen E, Kaprio J, Kaunisto MA, Heath AC, Montgomery GW, Göbel H, Todt U, Ferrari MD, Launer LJ, Frants RR, Terwindt GM, de Vries B, Verschuren WM, Brand J, Freilinger T, Pfaffenrath V, Straube A, Ballinger DG, Zhan Y, Daly MJ, Cox DR, Dichgans M, van den Maagdenberg AM, Kubisch C, Martin NG, Wessman M, Peltonen L, Palotie A.

Hum Mol Genet. 2008 Nov 1;17(21):3318-31. doi: 10.1093/hmg/ddn227. Epub 2008 Aug 2.

2.

Catechol-O-methyltransferase (COMT) gene variants: possible association of the Val158Met variant with opiate addiction in Hispanic women.

Oosterhuis BE, LaForge KS, Proudnikov D, Ho A, Nielsen DA, Gianotti R, Barral S, Gordon D, Leal SM, Ott J, Kreek MJ.

Am J Med Genet B Neuropsychiatr Genet. 2008 Sep 5;147B(6):793-8. doi: 10.1002/ajmg.b.30716.

3.

The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor.

Kroslak T, Laforge KS, Gianotti RJ, Ho A, Nielsen DA, Kreek MJ.

J Neurochem. 2007 Oct;103(1):77-87.

4.

Prodynorphin gene promoter repeat associated with cocaine/alcohol codependence.

Williams TJ, LaForge KS, Gordon D, Bart G, Kellogg S, Ott J, Kreek MJ.

Addict Biol. 2007 Sep;12(3-4):496-502. Epub 2007 Jun 8.

PMID:
17559549
5.

Opioid dependence and addiction during opioid treatment of chronic pain.

Ballantyne JC, LaForge KS.

Pain. 2007 Jun;129(3):235-55. Epub 2007 May 4. Review. Erratum in: Pain. 2007 Oct;131(3):350.

PMID:
17482363
6.
7.

Altered levels of basal cortisol in healthy subjects with a 118G allele in exon 1 of the Mu opioid receptor gene.

Bart G, LaForge KS, Borg L, Lilly C, Ho A, Kreek MJ.

Neuropsychopharmacology. 2006 Oct;31(10):2313-7. Epub 2006 Jun 21.

8.

Association analysis of polymorphisms in serotonin 1B receptor (HTR1B) gene with heroin addiction: a comparison of molecular and statistically estimated haplotypes.

Proudnikov D, LaForge KS, Hofflich H, Levenstien M, Gordon D, Barral S, Ott J, Kreek MJ.

Pharmacogenet Genomics. 2006 Jan;16(1):25-36.

PMID:
16344719
9.

Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction.

Kreek MJ, Nielsen DA, Butelman ER, LaForge KS.

Nat Neurosci. 2005 Nov;8(11):1450-7. Review.

PMID:
16251987
10.

Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments.

Kreek MJ, Bart G, Lilly C, LaForge KS, Nielsen DA.

Pharmacol Rev. 2005 Mar;57(1):1-26. Review.

PMID:
15734726
11.

Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction.

Yuferov V, Fussell D, LaForge KS, Nielsen DA, Gordon D, Ho A, Leal SM, Ott J, Kreek MJ.

Pharmacogenetics. 2004 Dec;14(12):793-804.

12.

Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden.

Bart G, Kreek MJ, Ott J, LaForge KS, Proudnikov D, Pollak L, Heilig M.

Neuropsychopharmacology. 2005 Feb;30(2):417-22.

13.

High-throughput molecular haplotype analysis (allelic assignment) of single-nucleotide polymorphisms by fluorescent polymerase chain reaction.

Proudnikov D, LaForge KS, Kreek MJ.

Anal Biochem. 2004 Dec 1;335(1):165-7. No abstract available.

PMID:
15519584
14.

Evolving perspectives on neurobiological research on the addictions: celebration of the 30th anniversary of NIDA.

Kreek MJ, Schlussman SD, Bart G, Laforge KS, Butelman ER.

Neuropharmacology. 2004;47 Suppl 1:324-44. Review.

PMID:
15464148
15.
16.

Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden.

Bart G, Heilig M, LaForge KS, Pollak L, Leal SM, Ott J, Kreek MJ.

Mol Psychiatry. 2004 Jun;9(6):547-9. No abstract available.

17.

Genes associated with addiction: alcoholism, opiate, and cocaine addiction.

Kreek MJ, Nielsen DA, LaForge KS.

Neuromolecular Med. 2004;5(1):85-108. Review.

PMID:
15001815
18.

Acute 'binge' cocaine administration elevates dynorphin mRNA in the caudate putamen of C57BL/6J but not 129/J mice.

Schlussman SD, Zhang Y, Yuferov V, LaForge KS, Ho A, Kreek MJ.

Brain Res. 2003 Jun 6;974(1-2):249-53.

PMID:
12742644
19.

Differential gene expression in the rat caudate putamen after "binge" cocaine administration: advantage of triplicate microarray analysis.

Yuferov V, Kroslak T, Laforge KS, Zhou Y, Ho A, Kreek MJ.

Synapse. 2003 Jun 15;48(4):157-69.

PMID:
12687634
20.

Quantification of multiple mRNA levels in rat brain regions using real time optical PCR.

Proudnikov D, Yuferov V, LaForge KS, Ho A, Jeanne Kreek M.

Brain Res Mol Brain Res. 2003 Apr 10;112(1-2):182-5.

PMID:
12670717
21.

The Kreek-McHugh-Schluger-Kellogg scale: a new, rapid method for quantifying substance abuse and its possible applications.

Kellogg SH, McHugh PF, Bell K, Schluger JH, Schluger RP, LaForge KS, Ho A, Kreek MJ.

Drug Alcohol Depend. 2003 Mar 1;69(2):137-50.

PMID:
12609695
22.

Optimizing primer--probe design for fluorescent PCR.

Proudnikov D, Yuferov V, Zhou Y, LaForge KS, Ho A, Kreek MJ.

J Neurosci Methods. 2003 Feb 15;123(1):31-45.

PMID:
12581847
23.

"Binge" cocaine differentially alters preproenkephalin mRNA levels in guinea pig brain.

LaForge KS, Yuferov V, Zhou Y, Ho A, Nyberg F, Jeanne Kreek M.

Brain Res Bull. 2003 Jan 30;59(5):353-7.

PMID:
12507685
24.

Pharmacotherapy of addictions.

Kreek MJ, LaForge KS, Butelman E.

Nat Rev Drug Discov. 2002 Sep;1(9):710-26. Review. Erratum in: Nat Rev Drug Discov 2002 Nov;1(11):920.

PMID:
12209151
25.

Potentially functional polymorphism in the promoter region of prodynorphin gene may be associated with protection against cocaine dependence or abuse.

Chen AC, LaForge KS, Ho A, McHugh PF, Kellogg S, Bell K, Schluger RP, Leal SM, Kreek MJ.

Am J Med Genet. 2002 May 8;114(4):429-35.

26.

Ablation of pituitary pro-opiomelanocortin (POMC) cells produces alterations in hypothalamic POMC mRNA levels and midbrain mu opioid receptor binding in a conditional transgenic mouse model.

Zhou Y, Unterwald EM, Ho A, LaForge KS, Yuferov VP, Kreuter J, Sirianni MJ, Allen RG, Kreek MJ.

J Neuroendocrinol. 2001 Sep;13(9):808-17.

PMID:
11578531
27.
28.

Elevation of guinea pig brain preprodynorphin mRNA expression and hypothalamic-pituitary-adrenal axis activity by "binge" pattern cocaine administration.

Yuferov V, Zhou Y, LaForge KS, Spangler R, Ho A, Kreek MJ.

Brain Res Bull. 2001 May 1;55(1):65-70.

PMID:
11427339
29.

Opioid receptor and peptide gene polymorphisms: potential implications for addictions.

LaForge KS, Yuferov V, Kreek MJ.

Eur J Pharmacol. 2000 Dec 27;410(2-3):249-268. Review. Erratum in: Eur J Pharmacol 2001 Aug 24;426(1-2):145.

PMID:
11134674
30.
31.

Comparison of methods for quantitation of radioactivity in protected hybrids in RNase protection assays.

Pham K, LaForge KS, Kreek MJ.

Biotechniques. 1998 Aug;25(2):198-200, 202, 204 passim. No abstract available.

32.

Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.

Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L, Gong J, Schluger J, Strong JA, Leal SM, Tischfield JA, Kreek MJ, Yu L.

Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9608-13.

33.

Regional quantitation of preprodynorphin mRNA in guinea pig gastrointestinal tract.

Yuferov VP, Culpepper-Morgan JA, LaForge KS, Ho A, Kreek MJ.

Neurochem Res. 1998 Apr;23(4):505-11.

PMID:
9566584
34.

Distribution of nociceptin/orphanin FQ receptor transcript in human central nervous system and immune cells.

Peluso J, LaForge KS, Matthes HW, Kreek MJ, Kieffer BL, Gavériaux-Ruff C.

J Neuroimmunol. 1998 Jan;81(1-2):184-92.

PMID:
9521621
35.

Distribution and polysome association of full-length and 3' truncated preproenkephalin mRNA in the guinea-pig brain.

LaForge KS, Ho A, Kreek MJ.

Brain Res Mol Brain Res. 1997 Jun;46(1-2):169-76.

PMID:
9191091
36.

Guinea pig preprodynorphin mRNA: primary structure and regional quantitation in the brain.

Yuferov VP, Laforge KS, Spangler R, Maggos CE, Kreek MJ.

DNA Cell Biol. 1996 Dec;15(12):1105-12.

PMID:
8985124
37.

Steady-state methadone in rats does not change mRNA levels of corticotropin-releasing factor, its pituitary receptor or proopiomelanocortin.

Zhou Y, Spangler R, Maggos CE, LaForge KS, Ho A, Kreek MJ.

Eur J Pharmacol. 1996 Nov 7;315(1):31-5.

PMID:
8960861
39.

Modulation of CRF-R1 mRNA in rat anterior pituitary by dexamethasone: correlation with POMC mRNA.

Zhou Y, Spangler R, LaForge KS, Maggos CE, Ho A, Kreek MJ.

Peptides. 1996;17(3):435-41.

PMID:
8735970
41.
43.

Isolation and sequence of the canine pancreatic phospholipase A2 gene.

Kerfelec B, LaForge KS, Vasiloudes P, Puigserver A, Scheele GA.

Eur J Biochem. 1990 Jun 20;190(2):299-304.

44.

Structure of the canine pancreatic lipase gene.

Mickel FS, Weidenbach F, Swarovsky B, LaForge KS, Scheele GA.

J Biol Chem. 1989 Aug 5;264(22):12895-901.

45.

Primary structures of canine pancreatic lipase and phospholipase A2 messenger RNAs.

Kerfelec B, LaForge KS, Puigserver A, Scheele G.

Pancreas. 1986;1(5):430-7.

PMID:
3562437
47.
48.

Expression of the native alpha and beta interferon genes in human cells.

May LT, Sehgal PB, LaForge KS, Inouye M.

Virology. 1983 Aug;129(1):116-26.

PMID:
6612995
49.

Isolation of novel human genomic DNA clones related to human interferon-beta 1 cDNA.

Sehgal PB, May LT, Sagar AD, LaForge KS, Inouye M.

Proc Natl Acad Sci U S A. 1983 Jun;80(12):3632-6.

50.

Unusually long mRNA species coding for human alpha and beta interferons.

Sehgal PB, May LT, LaForge KS, Inouye M.

Proc Natl Acad Sci U S A. 1982 Nov;79(22):6932-6.

Supplemental Content

Loading ...
Support Center